Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.39 USD | -5.55% | -5.46% | +69.77% |
14/05 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
13/05 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.77% | 28Cr | |
+54.05% | 6.39TCr | |
-2.02% | 4.18TCr | |
+40.01% | 4.05TCr | |
-10.22% | 2.72TCr | |
+13.42% | 2.65TCr | |
-21.60% | 1.87TCr | |
+2.89% | 1.27TCr | |
+22.40% | 1.21TCr | |
+27.49% | 1.21TCr |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target